SMT201700053B - Derivato del cicloalcano - Google Patents

Derivato del cicloalcano

Info

Publication number: SMT201700053B
Authority: SM; San Marino
Prior art keywords: cycloalcan; derivative; cycloalcan derivative
Prior art date: 2012-02-09

Application number

SM201700053T

Other languages

English (en)

Inventor

Tsuyoshi Shinozuka

Hiroyuki Kobayashi

Sayaka Suzuki

Kyosuke Tanaka

Hiroko Kimoto

Yuki Domon

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-02-09

Filing date

2017-01-24

Publication date

2017-03-08

2017-01-24 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2017-03-08 Publication of SMT201700053B publication Critical patent/SMT201700053B/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SM201700053T 2012-02-09 2017-01-24 Derivato del cicloalcano SMT201700053B (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2012025754		2012-02-09
JP2012259122		2012-11-27
PCT/JP2013/052985 WO2013118854A1 (ja)	2012-02-09	2013-02-08	シクロアルカン誘導体

Publications (1)

Publication Number	Publication Date
SMT201700053B true SMT201700053B (it)	2017-03-08

Family

ID=48947609

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM20170053T SMT201700053T1 (it)	2012-02-09	2013-02-08	Derivato del cicloalcano
SM201700053T SMT201700053B (it)	2012-02-09	2017-01-24	Derivato del cicloalcano

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SM20170053T SMT201700053T1 (it)	2012-02-09	2013-02-08	Derivato del cicloalcano

Country Status (30)

Country	Link
US (3)	US8889741B2 (it)
EP (2)	EP2813491B1 (it)
JP (2)	JP5997710B2 (it)
KR (1)	KR20140127238A (it)
CN (1)	CN104185629B (it)
AU (1)	AU2013218592B2 (it)
BR (1)	BR112014019478A2 (it)
CA (1)	CA2864222C (it)
CO (1)	CO7151511A2 (it)
CY (1)	CY1118572T1 (it)
DK (1)	DK2813491T3 (it)
ES (2)	ES2659434T3 (it)
HR (1)	HRP20161713T1 (it)
HU (2)	HUE037048T2 (it)
IL (1)	IL234014A (it)
IN (1)	IN2014MN01577A (it)
LT (1)	LT2813491T (it)
MX (1)	MX349354B (it)
NZ (1)	NZ628096A (it)
PH (2)	PH12014501804A1 (it)
PL (1)	PL2813491T3 (it)
PT (1)	PT2813491T (it)
RS (1)	RS55671B1 (it)
RU (1)	RU2635354C2 (it)
SG (1)	SG11201404707VA (it)
SI (1)	SI2813491T1 (it)
SM (2)	SMT201700053T1 (it)
TW (1)	TWI612042B (it)
WO (1)	WO2013118854A1 (it)
ZA (1)	ZA201405801B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8933236B2 (en)	2012-05-22	2015-01-13	Xenon Pharmaceuticals Inc.	N-substituted benzamides and methods of use thereof
RU2014121983A (ru)	2011-10-31	2015-12-10	Ксенон Фармасьютикалз Инк.	Биарильные простоэфирные сульфонамиды и их применение в качестве терапевтических средств
CN104024251B (zh) *	2011-10-31	2017-08-11	克赛农制药股份有限公司	苯磺酰胺化合物及其作为治疗剂的用途
US8889741B2 (en) *	2012-02-09	2014-11-18	Daiichi Sankyo Company, Limited	Cycloalkane derivatives
CA2878478A1 (en)	2012-07-06	2014-01-09	Genentech, Inc.	N-substituted benzamides and methods of use thereof
WO2014142221A1 (ja) *	2013-03-14	2014-09-18	第一三共株式会社	呼吸器疾患用薬
JP6096370B2 (ja)	2013-03-14	2017-03-15	ジェネンテック，インコーポレイテッド	置換トリアゾロピリジンとその使用方法
CA2898680A1 (en)	2013-03-15	2014-09-18	Genentech,Inc.	Substituted benzoxazoles and methods of use thereof
EA201691085A1 (ru)	2013-11-27	2017-02-28	Дженентек, Инк.	Замещенные бензамиды и способы их применения
US10005724B2 (en)	2014-07-07	2018-06-26	Genentech, Inc.	Therapeutic compounds and methods of use thereof
JP2018520107A (ja)	2015-05-22	2018-07-26	ジェネンテック，インコーポレイテッド	置換ベンズアミド及びその使用方法
CN108137477A (zh)	2015-08-27	2018-06-08	基因泰克公司	治疗化合物及其使用方法
RU2018115718A (ru)	2015-09-28	2019-10-28	Дженентек, Инк.	Терапевтические соединения и способы их применения
CN108349894A (zh)	2015-11-06	2018-07-31	第三共株式会社	除去二甲氧基苄基的方法
CN108495851A (zh)	2015-11-25	2018-09-04	基因泰克公司	取代的苯甲酰胺及其使用方法
US10766858B2 (en)	2016-03-30	2020-09-08	Genentech, Inc.	Substituted benzamides and methods of use thereof
CA3023465A1 (en) *	2016-05-20	2017-11-23	Xenon Pharmaceuticals Inc.	Benzenesulfonamide compounds and their use as therapeutic agents
SG11201903348UA (en) *	2016-10-17	2019-05-30	Genentech Inc	Therapeutic compounds and methods of use thereof
JP7072569B2 (ja) *	2016-10-27	2022-05-20	ブリストル－マイヤーズスクイブカンパニー	アシルスルホンアミドＮａＶ１．７阻害剤
MX2019006697A (es)	2016-12-09	2019-08-16	Xenon Pharmaceuticals Inc	Compuestos de bencenosulfonamida y su uso como agentes terapeuticos.
EP3601273B1 (en)	2017-03-24	2021-12-01	Genentech, Inc.	4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
AU2018338098B2 (en)	2017-09-20	2024-02-22	Abm Therapeutics Corporation	Cyclic iminopyrimidine derivatives as kinase inhibitors
JP2021514980A (ja) *	2018-02-26	2021-06-17	ジェネンテック，インコーポレイテッド	疼痛及び関連病態に対するピリジン−スルホンアミド化合物及びその使用
CN111936494A (zh)	2018-03-30	2020-11-13	豪夫迈·罗氏有限公司	作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
TW202003490A (zh)	2018-05-22	2020-01-16	瑞士商赫孚孟拉羅股份公司	治療性化合物及其使用方法
EA202092719A1 (ru)	2018-06-13	2021-03-16	Ксенон Фармасьютикалз Инк.	Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
AU2019331005B2 (en)	2018-08-31	2024-03-28	Xenon Pharmaceuticals Inc.	Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
MA53488A (fr)	2018-08-31	2021-12-08	Xenon Pharmaceuticals Inc	Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
US12110287B2 (en)	2018-12-26	2024-10-08	Raqualia Pharma Inc.	Heterocyclic derivatives as Nav1.7 and Nav1.8 blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6222048B1 (en)	1995-12-18	2001-04-24	Merck Frosst Canada & Co.	Diaryl-2-(5H)-furanones as Cox-2 inhibitors
WO2006038594A1 (ja)	2004-10-04	2006-04-13	Ono Pharmaceutical Co., Ltd.	Ｎ型カルシウムチャネル阻害薬
AU2006247478A1 (en) *	2005-05-16	2006-11-23	Vertex Pharmaceuticals Incorporated	Bicyclic derivatives as modulators of ion channels
CA2693588C (en)	2007-07-13	2015-11-17	Icagen, Inc.	Sodium channel inhibitors
WO2010035166A1 (en)	2008-09-23	2010-04-01	Pfizer Limited	Benzamide derivatives
WO2010079443A1 (en) *	2009-01-12	2010-07-15	Pfizer Limited	Sulfonamide derivatives
ES2532356T3 (es) *	2010-07-09	2015-03-26	Pfizer Limited	N-sulfonilbenzamidas como inhibidores de los canales de sodio dependientes de voltaje
WO2012004714A2 (en)	2010-07-09	2012-01-12	Pfizer Limited	Chemical compounds
WO2012004743A1 (en) *	2010-07-09	2012-01-12	Pfizer Limited	Benzenesulfonamides useful as sodium channel inhibitors
CN104024251B (zh) *	2011-10-31	2017-08-11	克赛农制药股份有限公司	苯磺酰胺化合物及其作为治疗剂的用途
US8889741B2 (en) *	2012-02-09	2014-11-18	Daiichi Sankyo Company, Limited	Cycloalkane derivatives

2013
- 2013-01-31 US US13/756,173 patent/US8889741B2/en active Active
- 2013-02-07 TW TW102104725A patent/TWI612042B/zh not_active IP Right Cessation
- 2013-02-08 EP EP13746373.3A patent/EP2813491B1/en active Active
- 2013-02-08 BR BR112014019478A patent/BR112014019478A2/pt not_active Application Discontinuation
- 2013-02-08 KR KR1020147021798A patent/KR20140127238A/ko not_active Abandoned
- 2013-02-08 AU AU2013218592A patent/AU2013218592B2/en not_active Ceased
- 2013-02-08 LT LTEP13746373.3T patent/LT2813491T/lt unknown
- 2013-02-08 PL PL13746373T patent/PL2813491T3/pl unknown
- 2013-02-08 ES ES16193142.3T patent/ES2659434T3/es active Active
- 2013-02-08 SI SI201330423A patent/SI2813491T1/sl unknown
- 2013-02-08 IN IN1577MUN2014 patent/IN2014MN01577A/en unknown
- 2013-02-08 RS RS20170101A patent/RS55671B1/sr unknown
- 2013-02-08 HU HUE16193142A patent/HUE037048T2/hu unknown
- 2013-02-08 MX MX2014009637A patent/MX349354B/es active IP Right Grant
- 2013-02-08 SG SG11201404707VA patent/SG11201404707VA/en unknown
- 2013-02-08 RU RU2014136463A patent/RU2635354C2/ru not_active IP Right Cessation
- 2013-02-08 ES ES13746373.3T patent/ES2613078T3/es active Active
- 2013-02-08 PT PT137463733T patent/PT2813491T/pt unknown
- 2013-02-08 DK DK13746373.3T patent/DK2813491T3/en active
- 2013-02-08 NZ NZ628096A patent/NZ628096A/en not_active IP Right Cessation
- 2013-02-08 WO PCT/JP2013/052985 patent/WO2013118854A1/ja active Application Filing
- 2013-02-08 HR HRP20161713TT patent/HRP20161713T1/hr unknown
- 2013-02-08 EP EP16193142.3A patent/EP3144300B1/en not_active Not-in-force
- 2013-02-08 CA CA2864222A patent/CA2864222C/en not_active Expired - Fee Related
- 2013-02-08 CN CN201380017715.1A patent/CN104185629B/zh not_active Expired - Fee Related
- 2013-02-08 HU HUE13746373A patent/HUE031450T2/en unknown
- 2013-02-08 JP JP2013557586A patent/JP5997710B2/ja not_active Expired - Fee Related
- 2013-02-08 SM SM20170053T patent/SMT201700053T1/it unknown
2014
- 2014-08-06 ZA ZA2014/05801A patent/ZA201405801B/en unknown
- 2014-08-07 IL IL234014A patent/IL234014A/en not_active IP Right Cessation
- 2014-08-11 PH PH12014501804A patent/PH12014501804A1/en unknown
- 2014-09-05 CO CO14195847A patent/CO7151511A2/es unknown
- 2014-09-30 US US14/502,708 patent/US9493448B2/en not_active Expired - Fee Related
2015
- 2015-11-27 PH PH12015502675A patent/PH12015502675A1/en unknown
2016
- 2016-08-26 JP JP2016165515A patent/JP6154052B2/ja not_active Expired - Fee Related
- 2016-09-19 US US15/269,485 patent/US9845313B2/en not_active Expired - Fee Related
2017
- 2017-01-24 SM SM201700053T patent/SMT201700053B/it unknown
- 2017-01-31 CY CY20171100142T patent/CY1118572T1/el unknown

Also Published As

Publication number	Publication date
ES2613078T3 (es)	2017-05-22
CA2864222C (en)	2016-10-25
BR112014019478A2 (pt)	2019-05-28
HUE037048T2 (hu)	2018-08-28
CN104185629A (zh)	2014-12-03
KR20140127238A (ko)	2014-11-03
MX349354B (es)	2017-07-24
EP2813491B1 (en)	2016-11-02
US20150018551A1 (en)	2015-01-15
RU2635354C2 (ru)	2017-11-13
WO2013118854A1 (ja)	2013-08-15
HUE031450T2 (en)	2017-07-28
PH12015502675A1 (en)	2017-04-24
US9493448B2 (en)	2016-11-15
LT2813491T (lt)	2017-02-10
EP3144300A1 (en)	2017-03-22
SI2813491T1 (sl)	2017-02-28
AU2013218592A1 (en)	2014-09-18
PH12014501804B1 (en)	2014-11-17
JP5997710B2 (ja)	2016-09-28
PH12014501804A1 (en)	2014-11-17
EP2813491A1 (en)	2014-12-17
DK2813491T3 (en)	2017-02-13
JPWO2013118854A1 (ja)	2015-05-11
US20170001984A1 (en)	2017-01-05
HK1203503A1 (en)	2015-10-30
PT2813491T (pt)	2017-02-10
RS55671B1 (sr)	2017-06-30
EP3144300B1 (en)	2017-12-20
IN2014MN01577A (it)	2015-05-08
NZ628096A (en)	2016-06-24
AU2013218592B2 (en)	2016-12-22
EP2813491A4 (en)	2015-08-12
CO7151511A2 (es)	2014-12-29
JP2017008093A (ja)	2017-01-12
CA2864222A1 (en)	2013-08-15
IL234014A (en)	2017-09-28
JP6154052B2 (ja)	2017-06-28
SMT201700053T1 (it)	2017-03-08
IL234014A0 (en)	2014-09-30
CY1118572T1 (el)	2017-07-12
SG11201404707VA (en)	2014-10-30
HRP20161713T1 (hr)	2017-02-10
US20140045862A1 (en)	2014-02-13
ES2659434T3 (es)	2018-03-15
TWI612042B (zh)	2018-01-21
CN104185629B (zh)	2017-10-13
MX2014009637A (es)	2015-06-23
PL2813491T3 (pl)	2017-08-31
US9845313B2 (en)	2017-12-19
TW201339152A (zh)	2013-10-01
ZA201405801B (en)	2015-12-23
RU2014136463A (ru)	2016-03-27
US8889741B2 (en)	2014-11-18

Publication	Publication Date	Title
CY2022027I1 (el)	2023-01-05	Παραγωγα βενζιμιδαζολο-προλινης
SMT201700053B (it)	2017-03-08	Derivato del cicloalcano
SMT201700065B (it)	2017-03-08	Derivato piridonico
DK2859055T3 (da)	2021-02-22	Polymercoatings
DK2825087T3 (da)	2019-05-13	Otoscanner
EP2838490A4 (en)	2015-12-23	TUBE FASTENING SYSTEM
EP2809145A4 (en)	2015-09-16	CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da)	2020-09-14	Ikke-disruptiv-gen-targetering
EP2814472A4 (en)	2015-11-04	DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en)	2016-02-24	Charging cable
EP2847405A4 (en)	2016-03-02	DOOR CLOSURE SYSTEM
EP2805877A4 (en)	2015-09-09	UNDER HOOD
DK2873977T3 (da)	2020-06-08	Dobbeltdækker-rørdispenser
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
DK2854722T3 (da)	2020-08-24	Stomipose
EP2831482A4 (en)	2015-12-16	Flange gasket
EP2816694A4 (en)	2015-10-28	FLAT CABLE WINDING DEVICE
EP2941099A4 (en)	2016-08-24	SWITCHING DEVICE
EP2899849A4 (en)	2016-05-25	STATOR FASTENING STRUCTURE
DK2825157T3 (da)	2019-01-02	Aminosyrelipider
EP2812047A4 (en)	2015-10-21	ACCESS SYSTEM VIA AN OCCLUSION
EP2862861A4 (en)	2015-04-22	PIPERIDINYLPYRAZOLOPYRIDINDERIVAT
EP2809729A4 (en)	2015-09-02	Siloxane polyether copolymers
EP2869113A4 (en)	2015-12-02	DISPLAY DEVICE FOR VEHICLE
EP2862179A4 (en)	2016-06-01	FUEL CURRENT INSPECTION PROBE